Lars Retterstøl
Position:
Phone:
Email:
 

Author network for Lars Retterstøl by COREMINE medical


Publications 2016

Møllersen L, Moldestad O, Rowe AD, Bjølgerud A, Holm I, Tveterås L, Klungland A, Retterstøl L (2016)
Effects of Anthocyanins on CAG Repeat Instability and Behaviour in Huntington's Disease R6/1 Mice
PLoS Curr, 8
PubMed 27540492

Publications 2015

Horn MA, Mikaelsen KB, Ferdinandusse S, Jørum E, Mellgren SI, Retterstøl L, Wanders RJ, Tallaksen CM (2015)
Mild phenotype in an adult male with X-linked adrenoleukodystrophy - case report
Clin Case Rep, 4 (2), 177-81
PubMed 26862418

Publications 2014

Horn MA, Retterstøl L, Abdelnoor M, Skjeldal OH, Tallaksen CM (2014)
Age-dependent penetrance among females with X-linked adrenoleukodystrophy
Brain, 138 (Pt 2), e325
PubMed 25149409

Publications 2013

Horn MA, Retterstøl L, Abdelnoor M, Skjeldal OH, Tallaksen CM (2013)
Adrenoleukodystrophy in Norway: high rate of de novo mutations and age-dependent penetrance
Pediatr Neurol, 48 (3), 212-9
PubMed 23419472

Wangensteen T, Retterstøl L, Rødningen OK, Hjelmesaeth J, Aukrust P, Halvorsen B (2013)
De novo 19p13.2 microdeletion encompassing the insulin receptor and resistin genes in a patient with obesity and learning disability
Am J Med Genet A, 161A (6), 1480-6
PubMed 23637016

Publications 2010

Wangensteen T, Akselsen H, Holmen J, Undlien D, Retterstøl L (2010)
A common haplotype in NAPEPLD is associated with severe obesity in a Norwegian population-based cohort (the HUNT study)
Obesity (Silver Spring), 19 (3), 612-7
PubMed 20885390

Wangensteen T, Egeland T, Akselsen H, Holmen J, Undlien D, Retterstøl L (2010)
FTO genotype and weight gain in obese and normal weight adults from a Norwegian population based cohort (the HUNT study)
Exp Clin Endocrinol Diabetes, 118 (9), 649-52
PubMed 20373279

Publications 2009

van Walsem MR, Sundet K, Retterstøl L, Sundseth Ø (2009)
A double blind evaluation of cognitive decline in a Norwegian cohort of asymptomatic carriers of Huntington's disease
J Clin Exp Neuropsychol, 32 (6), 590-8
PubMed 19916101

Wangensteen T, Kolsgaard ML, Mattingsdal M, Joner G, Tonstad S, Undlien D, Retterstol L (2009)
Mutations in the melanocortin 4 receptor (MC4R) gene in obese patients in Norway
Exp Clin Endocrinol Diabetes, 117 (6), 266-73
PubMed 19301229

Publications 2007

Djurovic S, Berge KE, Birkenes B, Braaten Ø, Retterstøl L (2007)
The effect of red wine on plasma leptin levels and vasoactive factors from adipose tissue: a randomized crossover trial
Alcohol Alcohol, 42 (6), 525-8
PubMed 17670801

Farooqi IS, Wangensteen T, Collins S, Kimber W, Matarese G, Keogh JM, Lank E, Bottomley B, Lopez-Fernandez J, Ferraz-Amaro I, Dattani MT, Ercan O, Myhre AG, Retterstol L, Stanhope R, Edge JA, McKenzie S, Lessan N, Ghodsi M, De Rosa V, Perna F, Fontana S, Barroso I, Undlien DE, O'Rahilly S (2007)
Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor
N Engl J Med, 356 (3), 237-47
PubMed 17229951

Karlsen A, Retterstøl L, Laake P, Paur I, Bøhn SK, Sandvik L, Blomhoff R (2007)
Anthocyanins inhibit nuclear factor-kappaB activation in monocytes and reduce plasma concentrations of pro-inflammatory mediators in healthy adults
J Nutr, 137 (8), 1951-4
PubMed 17634269

Publications 2006

Retterstol L, Lyberg T, Aspelin T, Berg K (2006)
A twin study of nitric oxide levels measured by serum nitrite/nitrate
Twin Res Hum Genet, 9 (2), 210-4
PubMed 16611490

Publications 2005

Retterstol L, Berge KE, Braaten Ø, Eikvar L, Pedersen TR, Sandvik L (2005)
A daily glass of red wine: does it affect markers of inflammation?
Alcohol Alcohol, 40 (2), 102-5
PubMed 15642722

Wangensteen T, Undlien D, Tonstad S, Retterstøl L (2005)
[Genetic causes of obesity]
Tidsskr Nor Laegeforen, 125 (22), 3090-3
PubMed 16299561

Publications 2003

Retterstol L, Eikvar L, Berg K (2003)
A twin study of C-Reactive Protein compared to other risk factors for coronary heart disease
Atherosclerosis, 169 (2), 279-82
PubMed 12921979

Retterstol L, Paus B, Bohn M, Bakken A, Erikssen J, Malinow MR, Berg K (2003)
Plasma total homocysteine levels and prognosis in patients with previous premature myocardial infarction: a 10-year follow-up study
J Intern Med, 253 (3), 284-92
PubMed 12603495

Publications 2002

Mosdøl A, Christensen B, Retterstøl L, Thelle DS (2002)
Induced changes in the consumption of coffee alter ad libitum dietary intake and physical activity level
Br J Nutr, 87 (3), 261-6
PubMed 12064335

Retterstol L, Eikvar L, Bohn M, Bakken A, Erikssen J, Berg K (2002)
C-reactive protein predicts death in patients with previous premature myocardial infarction--a 10 year follow-up study
Atherosclerosis, 160 (2), 433-40
PubMed 11849668

Retterstol L, Eikvar L, Bohn M, Bakken A, Erikssen J, Berg K (2002)
C-reactive protein predicts death in patients with previous premature myocardial infarction - A 10 year follow-up study
Atherosclerosis, 160 (2), PII S0021-9150(01)00535-0-440

Publications 2001

Christensen B, Mosdol A, Retterstol L, Landaas S, Thelle DS (2001)
Abstention from filtered coffee reduces the concentrations of plasma homocysteine and serum cholesterol--a randomized controlled trial
Am J Clin Nutr, 74 (3), 302-7
PubMed 11522552

Retterstol L, Djurovic S, Bohn M, Bakken A, Erikssen J, Berg K (2001)
Plasma N-terminal pro-atrial natriuretic peptide predicts death after premature myocardial infarction, but not as well as radionuclide ejection fraction. A ten-year follow-up study
Scand Cardiovasc J, 35 (6), 373-8
PubMed 11837516

Retterstol L, Kierulf P, Pedersen JC, Bohn M, Bakken A, Erikssen J, Berg K (2001)
Plasma fibrinogen level and long-term prognosis in Norwegian middle-aged patients with previous myocardial infarction. A 10 year follow-up study
J Intern Med, 249 (6), 511-8
PubMed 11422657

Publications 1999

Christensen B, Landaas S, Stensvold I, Djurovic S, Retterstøl L, Ringstad J, Berg K, Thelle DS (1999)
Whole blood folate, homocysteine in serum, and risk of first acute myocardial infarction
Atherosclerosis, 147 (2), 317-26
PubMed 10559518

Publications 1995

Retterstøl L, Svane S (1995)
[Acute psychosis--an unusual clinical manifestation of primary hyperparathyroidism]
Tidsskr Nor Laegeforen, 115 (29), 3623-4
PubMed 8539717